Metabolic dysfunction-associated steatotic liver disease: the role of oxidative stress and emerging therapeutic strategies

Abstract Metabolic dysfunction-associated steatotic liver disease (MASLD) has attracted considerable global concern. Physical inactivity, excessive caloric intake and unhealthy lifestyle factors, have contributed to its development. Obesity and metabolic disorders are strongly correlated with MASLD. It is a complex condition marked by fat accumulation in the hepatocytes, which progresses to more severe stages such as metabolic dysfunction-associated steatohepatitis (MASH), fibrosis, cirrhosis, and hepatocellular carcinoma. Globally, MASLD affects ~ 32% of adults, with a higher prevalence in men and certain populations owing to genetic and metabolic factors. It is closely linked to metabolic syndromes like obesity, type 2 diabetes mellitus, and insulin resistance. Moreover, it affects nonobese individuals. MASLD progression is driven by oxidative stress (OS) resulting from an imbalance between lipid metabolism and antioxidant-based defense responses. Reactive Oxygen Species (ROS) play a crucial role in disease progression, inducing liver inflammation, lipid peroxidation, and immune cell activation. Key byproducts of OS, such as malondialdehyde and 4-hydroxynonenal, directly contribute to cell damage and inflammation. This study examined the pathophysiology of MASLD, focusing on the impact of OS on liver inflammation, fibrosis, and the progression from steatosis to steatohepatitis. It draws attention to the limits of the existing antioxidant treatments as well as the pathways through which ROS and metabolites linked to OS impact liver health. Additionally, it assesses the potential of modulating apoptosis, a consequence of prolonged OS, as a therapeutic approach to mitigating liver damage and metabolic dysregulation in MASLD.

Authors

Institutions

Publication Details

Journal
Egyptian Liver Journal
Published
2026-11-14
DOI
https://doi.org/10.1186/s43066-026-00572-x
Primary Topic
Liver Disease Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Metabolic dysfunction-associated steatotic liver disease: the role of oxidative stress and emerging therapeutic strategies

Faizul Azam, Rajesh Kumar Sharma, Abhilasha Tiwari, Joshua Gyedu Norman et al.
3 links
Egyptian Liver Journal
Liver Disease Diagnosis and Treatment
article

Metabolic dysfunction-associated steatotic liver disease: the role of oxidative stress and emerging therapeutic strategies

Faizul Azam, Rajesh Kumar Sharma, Abhilasha Tiwari, Joshua Gyedu Norman, Parveen Kumar, Sanjay Shinde
article en

Abstract

Abstract Metabolic dysfunction-associated steatotic liver disease (MASLD) has attracted considerable global concern. Physical inactivity, excessive caloric intake and unhealthy lifestyle factors, have contributed to its development. Obesity and metabolic disorders are strongly correlated with MASLD. It is a complex condition marked by fat accumulation in the hepatocytes, which progresses to more severe stages such as metabolic dysfunction-associated steatohepatitis (MASH), fibrosis, cirrhosis, and hepatocellular carcinoma. Globally, MASLD affects ~ 32% of adults, with a higher prevalence in men and certain populations owing to genetic and metabolic factors. It is closely linked to metabolic syndromes like obesity, type 2 diabetes mellitus, and insulin resistance. Moreover, it affects nonobese individuals. MASLD progression is driven by oxidative stress (OS) resulting from an imbalance between lipid metabolism and antioxidant-based defense responses. Reactive Oxygen Species (ROS) play a crucial role in disease progression, inducing liver inflammation, lipid peroxidation, and immune cell activation. Key byproducts of OS, such as malondialdehyde and 4-hydroxynonenal, directly contribute to cell damage and inflammation. This study examined the pathophysiology of MASLD, focusing on the impact of OS on liver inflammation, fibrosis, and the progression from steatosis to steatohepatitis. It draws attention to the limits of the existing antioxidant treatments as well as the pathways through which ROS and metabolites linked to OS impact liver health. Additionally, it assesses the potential of modulating apoptosis, a consequence of prolonged OS, as a therapeutic approach to mitigating liver damage and metabolic dysregulation in MASLD.

Egyptian Liver JournalVol. 16(1)
University of Ghana (GH), Qassim University (SA), NIMS University (IN), Ghana Health Service (GH)
Good health and well-being
Liver Disease Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon